Strength
2.2 mg/2mL
Manufacturer
Genentech, Inc.NDC
50242004164
Classification
Brand
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
1/1/2026
Active Ingredients
ALTEPLASEApproval Type
Biologic (BLA)
FDA Application
BLA103172On Market Since
9/4/2001
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
No related drugs found.